siRNA-Based Approach for Castration-Resistant Prostate Cancer Therapy Targeting Androgen Receptor Signaling Pathway - Supplementary material

Name: siRNA-Based Approach for Castration-Resistant Prostate Cancer Therapy Targeting Androgen Receptor Signaling Pathway - Supplementary material
Creator: Rcheulishvili, Nino; Papukashvili, Dimitri; Lu, Xiaoqing; Bai, Wenqi; Xi, Yanfeng; Xing, Nianzeng; Zhang, Huanhu; Yu, Yanling; Ren, Ruimin; Feng, Shunping
Published: 2023-10-12T00:00:00+08:00

Taylor & Francis Group2024-05-15 更新2026-04-16 收录

siRNA治疗

去势抵抗性前列腺癌

数据链接：

https://tandf.figshare.com/articles/dataset/siRNA-Based_Approach_for_Castration-Resistant_Prostate_Cancer_Therapy_Targeting_Androgen_Receptor_Signaling_Pathway_-_Supplementary_material/24297763/1 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Table 1. The major characteristics of CSPC and CRPC. CSPC, Castration-Sensitive Prostate Cancer; CRPC, Castration-Resistant Prostate Cancer.Supplementary Table 2. Interventional clinical trials of siRNA use for cancer. Search criteria: Cancer, siRNA. (Accessed in December 2022, sorted from the newest to the oldest start dates). U.S., United States; U.K., United Kingdom.

提供机构：

Rcheulishvili, Nino; Papukashvili, Dimitri; Lu, Xiaoqing; Bai, Wenqi; Xi, Yanfeng; Xing, Nianzeng; Zhang, Huanhu; Yu, Yanling; Ren, Ruimin; Feng, Shunping

创建时间：

2023-10-12